[Skip to Navigation]
Sign In
January 2019

Missing Conflict of Interest Disclosure

JAMA Otolaryngol Head Neck Surg. 2019;145(1):96. doi:10.1001/jamaoto.2018.3407

In the Original Investigation titled “Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: a Secondary Analysis of a Randomized Clinical Trial,”1 published in the September 2016 issue of JAMA Otolaryngology–Head & Neck Surgery, conflict of interest disclosures were not reported accurately by José Baselga, MD, PhD. Dr Baselga has written a Letter to the journal2 explaining this inconsistent reporting of potential conflict of interest disclosures. This article was corrected online.

Bonner  J, Giralt  J, Harari  P,  et al.  Cetuximab and radiotherapy in laryngeal preservation for cancers of the larynx and hypopharynx: a secondary analysis of a randomized clinical trial.  JAMA Otolaryngol Head Neck Surg. 2016;142(9):842-849. doi:10.1001/jamaoto.2016.1228PubMedGoogle ScholarCrossref
Baselga  J.  Failure to accurately disclose conflicts of interest in article published in JAMA Otolaryngology–Head & Neck Surgery  [published online October 26, 2018].  JAMA Otolaryngol Head Neck Surg. doi:10.1001/jamaoto.2018.3400PubMedGoogle Scholar